Maxtorin 100 mg Injection
  1. Home
  2. Pharma Products
  3. Pfizer Ltd
  4. Maxtorin 100 mg Injection

Maxtorin 100 mg Injection

Maxtorin 100 mg Injection contains bendamustine, an anticancer medicine used to treat certain blood cancers. It is used for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma in appropriate patients. The injection is administered by a qualified healthcare professional under medical supervision.

BUY NOW

Category

Maxtorin 100 mg Injection contains 100 mg of bendamustine and is supplied as a parenteral formulation. Bendamustine is an alkylating agent that interferes with DNA synthesis and damages cancer cells. It is administered intravenously according to the prescribed chemotherapy regimen and patient-specific requirements. Treatment should be planned and monitored by an oncology specialist, with appropriate laboratory monitoring during therapy.

Technical Specification

Specification Details
Active Ingredient Bendamustine 100 mg
Dosage Form Injection
Therapeutic Class Alkylating Agent
Main Indication Chronic Lymphocytic Leukemia
Route of Administration Intravenous
Pack Size 20 mL × 1 Vial

Product Also Known As

Maxtorin 100 mg Injection, Maxtorin 100 mg Vial, Maxtorin Bendamustine 100 mg Injection, Bendamustine 100 mg Injection, Bendamustine Hydrochloride Injection, Bendamustine Oncology Injection